Top Abstract Purchase Related
Home
>
Node
>
Subnode

Postoperative adjuvant chemotherapy for non-small cell lung cancer

Okamoto, T.; Ichinose, Y.

Gan to Kagaku Ryoho. Cancer and ChemoTherapy 32(6): 765-769

2005

ISSN/ISBN: 0385-0684
PMID: 15984513
Document Number: 590867
Patients with completely resected non-small-cell lung cancer (NSCLC) are subjects for postoperative adjuvant treatment. Recently, several randomized trials with a large number of enrolled patients have shown that platinum-based chemotherapy has potential for improving survival among patients with completely resected NSCLC in Western countries. In Japan, uracil-tegafur was also shown to improve survival among patients with completely resected stage I adenocarcinoma. This review evaluated the role of adjuvant chemotherapy, based on the results of randomized trials and meta-analyses.

Document emailed within 1 workday
Secure & encrypted payments

Marangolo, M.; Fiorentini, G. 1988: Adjuvant chemotherapy of non-small cell lung cancer: a review Seminars in Oncology 15(6 Suppl 7: 13-17
Dediu, M. 2001: Controversies in the treatment of non-small cell lung cancer; adjuvant chemotherapy Pneumologia 50(2): 115-117
Grants, E.A.; Berzinia, V.I.; Bashko, I.I.; Zitare, I.I.; Berzin'sh, I.A. 1989: The results of the adjuvant chemotherapy of patients with small-cell lung cancer Voprosy Onkologii 35(2): 172-174
Cortes, J.; Rodriguez, J.; Calvo, E. 2001: Adjuvant chemotherapy for completely resected non-small-cell lung cancer New England Journal of Medicine 344(9): 689; Author Reply 690
Socinski, M.A. 1999: The current status of adjuvant chemotherapy for resected non-small cell lung cancer Seminars in Oncology 26(5 Suppl 15: 27-33
Hirai, Y.; Shimizu, Y.; Oura, S.; Yoshimasu, T.; Ota, F.; Nakamura, R.; Naito, K.; Nishiguchi, H.; Hashimoto, S.; Okamura, Y. 2012: The importance of p53 and ras mutation as predictive markers for adjuvant chemotherapy in non-small-cell lung cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 39(3): 381-384
Uchida, T.; Nakakawaji, K.; Sakamoto, J. 1996: Administration of oral etoposide for one year as adjuvant chemotherapy for non-small cell lung cancer-side effect Gan to Kagaku Ryoho. Cancer and ChemoTherapy 23(14): 1967-1970
Yamaguchi, M.; Fukuyama, Y.; Ichinose, Y. 2003: Current status of the neo-adjuvant and adjuvant therapy for the resectable non-small cell lung cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 30(2): 203-208
Notsuda, H.; Endo, C.; Sakurada, A.; Okada, Y.; Kondo, T. 2009: Experience of postoperative adjuvant chemotherapy of lung cancer at outpatient department Kyobu Geka. Japanese Journal of Thoracic Surgery 62(13): 1111-5; discussion 1115--7
Naito, M.; Tsuboi, M. 2016: Recent Status of Postoperative Adjuvant Chemotherapy after Completely Resected Lung Cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 43(2): 165-169
Yohena, T.; Kuniyoshi, M.; Teruya, T.; Kawasaki, H.; Teruya, J.; Kawabata, T.; Ohta, M.; Ishikawa, K.; Oshiro, Y.; Chinen, T.; Uehara, T.; Hirayasu, T.; Ogawa, K.; Samura, H. 2008: A case of long-term survival of postoperative brain metastasis of small cell lung cancer effectively treated with chemotherapy, whole brain radiotherapy and stereotactic radiosurgery Gan to Kagaku Ryoho. Cancer and ChemoTherapy 35(2): 331-334
Williams, C.J.; Woods, R.; Levi, J.; Page, J. 1988: Chemotherapy for non-small cell lung cancer: a randomized trial of cisplatin/vindesine v no chemotherapy Seminars in Oncology 15(6 Suppl 7: 58-61
Ferguson, M.K.; Little, A.G.; Golomb, H.M.; Hoffman, P.C.; DeMeester, T.R.; Beveridge, R.; Skinner, D.B. 1986: The role of adjuvant therapy after resection of T1 N1 M0 and T2 N1 M0 non-small cell lung cancer Journal of Thoracic and Cardiovascular Surgery 91(3): 344-349
Xiao, Y.-Y.; Zhan, P.; Yuan, D.-M.; Liu, H.-B.; Lv, T.-F.; Shi, Y.; Song, Y. 2013: Chemotherapy plus Vandetanib or chemotherapy alone in advanced non-small cell lung cancer: a meta-analysis of four randomised controlled trials Clinical Oncology 25(1): E7
Momozane, T.; Higashiyama, M.; Maeda, J.; Okami, J.; Oda, K.; Imamura, F.; Yoneda, K.; Takenaka, A.; Kodama, K. 2009: Surgical treatment for the second double lung cancers following chemotherapy for small cell lung cancer Kyobu Geka. Japanese Journal of Thoracic Surgery 62(2): 117-121
Maneechawakajorn, J.; Suksuperm, J. 2014: Quality of life in advanced non-small cell lung cancer receiving chemotherapy of platinum combination in old versus new standard chemotherapy regimen Journal of the Medical Association of Thailand 97(Suppl 11): S69-S75
Tomeczko, J.; Napora, P.; Dlubek, D.; Pacuszko, T.; Bochenska, J.; Teucher, T.; Schmitz, H.; Lange, A. 1997: Adjuvant spleen ultrafiltrate immunotherapy in unresectable advanced non small cell lung cancer Arzneimittel-Forschung 47(12): 1411-1416
Movsas, B. 2001: Role of adjuvant therapy in resected stage II/IIIA non-small-cell lung cancer Oncology 15(12): 1549-1558
Carney, D.N.; Mitchell, J.B.; Kinsella, T.J. 1983: In vitro radiation and chemotherapy sensitivity of established cell lines of human small cell lung cancer and its large cell morphological variants Cancer Research 43(6): 2806-2811
Greco, F.A.; Johnson, D.H.; Hainsworth, J.D.; Wolff, S.N. 1985: Chemotherapy of small-cell lung cancer Seminars in Oncology 12(4 Suppl 6: 31-37